Curie Oncology, a private oncology network in Southeast Asia, has partnered with health‑tech firm Oncoshot to deploy AI‑powered clinical research tools to help patients gain faster access to cancer clinical trials.

• Technology: The partnership uses Oncoshot’s AI platform to transform unstructured clinical data into research‑ready datasets, enabling clinical and research teams to work more efficiently.
• Efficiency: The AI system extracts and de-identifies data with high accuracy, allowing research coordinators to spend more time on patient‑facing and trial‑critical tasks rather than manual data processing.
• Collaboration: Curie Oncology is among the first private oncology networks in Asia to deploy this AI platform, extending the technology’s use beyond earlier collaborations in the public sector.

This summary is based on a press release issued by Oncoshot.